Department of Otolaryngology-Head and Neck Surgery, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
Otol Neurotol. 2021 Mar 1;42(3):408-413. doi: 10.1097/MAO.0000000000002940.
To characterize failure rate and etiology after cochlear implantation; to identify predictors and describe outcomes after implant failure.
Retrospective chart review and systematic review of the literature using PubMed and Embase.
Academic Cochlear Implant Center.
Four hundred ninety-eight devices in 439 distinct adult patients.
Unilateral or bilateral cochlear implantation.
Implant failure rate and etiology.
A total of 32 devices (5.9%) failed in 31 patients encompassing the following failure types in accordance with the European Consensus Statement of Cochlear Implants: 17 device failures (53.1%), 11 failures due to performance decrement/adverse reactions (34.4%), and 4 medical reasons (12.9%). There was no significant difference in age, sex, or manufacturer between patients with and without failures. Twenty-five percent of patients with failure leading to explantation had childhood onset of deafness compared to 12.1% of patients with adult-onset hearing loss (OR = 2.42; p = 0.04). Performance decrement/adverse reaction patients had an older average age at implantation compared to device failure patients (mean 68.5 yr 95% CI: 59.9-77.1 vs mean 47.6 yr, CI: 39.9-55.3, p < 0.01). There was no significant difference in time to failure, sex, or device manufacturer between the different types of failures. Twenty-nine patients who experienced CI failure underwent a revision surgery, while the remaining two opted for explantation without reimplantation. One patient who underwent revision surgery subsequently presented with a second failure and underwent a second revision, which was successful.In our systematic review, 815 citations were reviewed, and 9 studies were selected for inclusion. Overall failure rate across all studies was 5.5%. Device failure was the leading cause of failure in the majority (6/9) of studies, accounting for 40.8% of all failures. Medical reasons were the second leading cause at 33.6%, followed by performance decrement/adverse reaction (20.9%) and other (4.8%).
Cochlear implant failure is a rare phenomenon. Childhood-onset of hearing loss appears to be associated with an increased risk of overall failure. Older patients are at increased risk for performance decrement/adverse reaction. Revision surgery success rates remain very high and patients with failure of any cause should be offered explantation with concurrent reimplantation.
描述人工耳蜗植入后的失败率和病因;确定预测因素并描述植入失败后的结果。
使用 PubMed 和 Embase 进行回顾性图表审查和系统综述。
学术人工耳蜗植入中心。
439 名成年患者中的 498 个设备。
单侧或双侧人工耳蜗植入。
植入物的失败率和病因。
31 名患者中有 32 个设备(5.9%)出现故障,符合欧洲人工耳蜗植入共识声明的以下故障类型:17 个设备故障(53.1%),11 个因性能下降/不良反应(34.4%)和 4 个医疗原因(12.9%)。失败和未失败患者的年龄、性别或制造商之间无显著差异。25%的故障导致取出的患者有儿童期耳聋,而 12.1%的患者有成人听力损失(OR=2.42;p=0.04)。与设备故障患者相比,出现性能下降/不良反应的患者植入时的平均年龄更大(平均 68.5 岁,95%CI:59.9-77.1 岁 vs 平均 47.6 岁,CI:39.9-55.3 岁,p<0.01)。不同类型的故障之间,故障时间、性别或设备制造商均无显著差异。29 名经历过 CI 失败的患者接受了修复手术,而其余 2 名患者选择了不重新植入的取出。一名接受修复手术的患者随后出现第二次失败并接受第二次修复,手术成功。在我们的系统综述中,共审查了 815 条引文,并选择了 9 项研究进行纳入。所有研究的总体失败率为 5.5%。设备故障是大多数(6/9)研究中失败的主要原因,占所有失败的 40.8%。医疗原因是第二大原因,占 33.6%,其次是性能下降/不良反应(20.9%)和其他(4.8%)。
人工耳蜗植入失败是一种罕见现象。儿童期听力损失似乎与整体失败风险增加有关。老年患者发生性能下降/不良反应的风险增加。修复手术成功率仍然非常高,任何原因导致失败的患者都应接受取出同时进行再次植入。